|
HY-127111-10mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-100mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-25mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-5mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-50mg
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-127111-1mL
|
MedChemexpress LLC
|
NDI-091143 [CAS 2375840-87-0] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-109066-10mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-100mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-5mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-50mg
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6]
|
|
COVID-19-immunoregulation
|
|
|
HY-109066-1mL
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-123812-1mg
|
MedChemexpress LLC
|
PF-03654764 [CAS 935840-35-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-122026-10mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-100mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-25mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-5mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-50mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-1mL
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-13344A-10mg
|
MedChemexpress LLC
|
PF-8380 (hydrochloride) [CAS 2070015-01-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13344A-100mg
|
MedChemexpress LLC
|
PF-8380 (hydrochloride) [CAS 2070015-01-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13344A-25mg
|
MedChemexpress LLC
|
PF-8380 (hydrochloride) [CAS 2070015-01-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13344A-5mg
|
MedChemexpress LLC
|
PF-8380 (hydrochloride) [CAS 2070015-01-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13344A-50mg
|
MedChemexpress LLC
|
PF-8380 (hydrochloride) [CAS 2070015-01-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-13344-10mg
|
MedChemexpress LLC
|
PF-8380 [CAS 1144035-53-9]
|
|
Cancer-Kinase/protease
|
|
|
HY-13344-100mg
|
MedChemexpress LLC
|
PF-8380 [CAS 1144035-53-9]
|
|
Cancer-Kinase/protease
|
|
